Simon Quick Advisors
CRVS icon

Simon Quick Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Simon Quick Advisors’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$288K Hold
25,000
– – 0.01% 368
2026
Q2 		$374K Buy
+25,000
New +$347K 0.02% 300

Other funds holding CRVS

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Jackson Square Capital
Jackson Square Capital San Francisco, California $667M AUM 118.76% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Avity Investment Management
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Western Pacific Wealth Management
Western Pacific Wealth Management Lake Forest, Illinois $119M AUM 20.8% 1-Year Est. Return

Simon Quick Advisors's CRVS Position: Q3 2026 in Review

Simon Quick Advisors held its Corvus Pharmaceuticals (CRVS) position steady in Q3 2026 at 25,000 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #368.

Simon Quick Advisors first reported a position in CRVS in Q2 2026 and has held it in 2 quarters since. The position peaked at $374K in Q2 2026. 22 funds tracked by Wall St. Rank hold CRVS as of Q3 2026.

  • Simon Quick Advisors held 25,000 shares of Corvus Pharmaceuticals worth $288K as of Q3 2026.
  • Simon Quick Advisors left its Corvus Pharmaceuticals share count unchanged in Q3 2026.
  • Corvus Pharmaceuticals made up 0.01% of Simon Quick Advisors's portfolio in Q3 2026, its #368 holding.
  • Simon Quick Advisors first reported a position in Corvus Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Simon Quick Advisors's Corvus Pharmaceuticals position peaked at $374K in Q2 2026.
  • 22 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q3 2026.

Based on Simon Quick Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.